Evidence supporting the use of: Cryptoxanthin
For the health condition: Macular Degeneration

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cryptoxanthin is a naturally occurring carotenoid found in various fruits and vegetables, such as papaya, oranges, and sweet red peppers. Carotenoids, including lutein and zeaxanthin, have well-established roles in supporting eye health and are commonly used in supplements for age-related macular degeneration (AMD). Cryptoxanthin, while structurally similar, has received less direct research attention compared to lutein and zeaxanthin. Some observational studies suggest that higher dietary intake of cryptoxanthin is associated with a reduced risk of certain eye diseases, including AMD, due to its antioxidant properties and potential to protect retinal cells from oxidative stress. However, the majority of clinical trials and large-scale studies on AMD prevention or treatment focus specifically on lutein and zeaxanthin, not cryptoxanthin. The AREDS2 (Age-Related Eye Disease Study 2) supplement formula, the gold standard for AMD, does not include cryptoxanthin. In summary, there is modest scientific rationale for considering cryptoxanthin beneficial for eye health, primarily based on its antioxidant activity and observational data. However, direct clinical evidence for its effectiveness in preventing or treating macular degeneration is limited, and it is not a standard or widely recommended ingredient for this condition. The current evidence base supports a low to moderate rating for cryptoxanthin’s use in AMD, acknowledging a potential role but lacking robust clinical validation.

More about cryptoxanthin
More about Macular Degeneration